|
Hiraga, Toru; Myoui, Akira; Hashimoto, Nobuyuki et al. (2012) Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. Cancer Res 72:4238-49
|
|
Hiraga, Toru; Williams, Paul J; Ueda, Akimi et al. (2004) Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model. Clin Cancer Res 10:4559-67
|
|
Mori, Yoshihisa; Shimizu, Nobuaki; Dallas, Mark et al. (2004) Anti-alpha4 integrin antibody suppresses the development of multiple myeloma and associated osteoclastic osteolysis. Blood 104:2149-54
|
|
Yoneda, Toshiyuki; Hashimoto, Nobuyuki; Hiraga, Toru (2004) Bisphosphonate actions on bone and visceral metastases. Cancer Treat Res 118:213-29
|
|
Myoui, Akira; Nishimura, Riko; Williams, Paul J et al. (2003) C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63:5028-33
|
|
Nishimura, Riko; Hata, Kenji; Ikeda, Fumiyo et al. (2003) The role of Smads in BMP signaling. Front Biosci 8:s275-84
|
|
Hata, Kenji; Nishimura, Riko; Ikeda, Fumiyo et al. (2003) Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor gamma during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell 14:545-55
|
|
Michigami, Toshimi; Hiraga, Toru; Williams, Paul J et al. (2002) The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs. Breast Cancer Res Treat 75:249-58
|
|
Nishimura, R; Hata, K; Harris, S E et al. (2002) Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5. Bone 31:303-12
|
|
Yi, Bing; Williams, Paul J; Niewolna, Marie et al. (2002) Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. Cancer Res 62:917-23
|
Showing the most recent 10 out of 28 publications
